IS6580A - Púrín afleiður - Google Patents

Púrín afleiður

Info

Publication number: IS6580A
Authority: IS; Iceland
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 2000-06-27

Application number

IS6580A

Other languages

English (en)

Inventor

John Mantell Simon

Marina Monaghan Sandra

Thomas Stephenson Peter

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-27

Filing date

2002-10-10

Publication date

2002-10-10

2002-10-10 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-10-10 Publication of IS6580A publication Critical patent/IS6580A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pregnancy & Childbirth (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)

IS6580A 2000-06-27 2002-10-10 Púrín afleiður IS6580A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0015727.1A GB0015727D0 (en)	2000-06-27	2000-06-27	Purine derivatives
PCT/IB2001/001064 WO2002000676A1 (en)	2000-06-27	2001-06-14	Purine derivatives

Publications (1)

Publication Number	Publication Date
IS6580A true IS6580A (is)	2002-10-10

Family

ID=9894500

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6580A IS6580A (is)	2000-06-27	2002-10-10	Púrín afleiður

Country Status (42)

Country	Link
EP (1)	EP1296996B1 (is)
JP (1)	JP2004501929A (is)
KR (1)	KR20030036248A (is)
CN (1)	CN1432020A (is)
AP (1)	AP1372A (is)
AR (1)	AR028759A1 (is)
AT (1)	ATE267836T1 (is)
AU (1)	AU2001264164A1 (is)
BG (1)	BG107171A (is)
BR (1)	BR0111912A (is)
CA (1)	CA2412564C (is)
CZ (1)	CZ20023992A3 (is)
DE (1)	DE60103537T2 (is)
DK (1)	DK1296996T3 (is)
DO (1)	DOP2001000195A (is)
EA (1)	EA200201291A1 (is)
EC (1)	ECSP024396A (is)
EE (1)	EE200200712A (is)
ES (1)	ES2220775T3 (is)
GB (1)	GB0015727D0 (is)
GT (1)	GT200100119A (is)
HR (1)	HRP20020995A2 (is)
HU (1)	HUP0301389A3 (is)
IL (1)	IL152529A0 (is)
IS (1)	IS6580A (is)
MA (1)	MA26918A1 (is)
MX (1)	MXPA03000078A (is)
NO (1)	NO20025975L (is)
NZ (1)	NZ521867A (is)
OA (1)	OA12294A (is)
PA (1)	PA8521001A1 (is)
PE (1)	PE20020213A1 (is)
PL (1)	PL361384A1 (is)
PT (1)	PT1296996E (is)
SI (1)	SI1296996T1 (is)
SK (1)	SK17332002A3 (is)
SV (1)	SV2002000507A (is)
TN (1)	TNSN01096A1 (is)
TR (1)	TR200401622T4 (is)
UY (1)	UY26797A1 (is)
WO (1)	WO2002000676A1 (is)
ZA (1)	ZA200209557B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7208505B2 (en)	2001-08-14	2007-04-24	Eli Lilly And Company	β3 adrenergic agonists
SE0201980D0 (sv) *	2002-06-24	2002-06-24	Astrazeneca Ab	Novel compounds
US6919356B2 (en)	2002-09-26	2005-07-19	Bristol Myers Squibb Company	N-substituted heterocyclic amines as modulators of chemokine receptor activity
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
PE20060272A1 (es)	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
NZ554506A (en) *	2004-09-20	2011-01-28	Inotek Pharmaceuticals Corp	Purine derivatives and methods of use thereof
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
EP1957530A2 (en)	2005-10-21	2008-08-20	Novartis AG	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
PT2013211E (pt) *	2006-04-21	2012-06-21	Novartis Ag	Derivados de purina para utilização como agonistas de receptores a2a de adenosina
US7589076B2 (en) *	2006-05-18	2009-09-15	Pgx Health, Llc	Substituted aryl piperidinylalkynyladenosines as A2AR agonists
EP2081933B1 (en)	2006-09-29	2011-03-23	Novartis AG	Pyrazolopyrimidines as pi3k lipid kinase inhibitors
MX2009004715A (es)	2006-10-30	2009-05-20	Novartis Ag	Compuestos heterociclicos como agentes antiinflamatorios.
US7897737B2 (en)	2006-12-05	2011-03-01	Lasergen, Inc.	3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
CN102264917B (zh) *	2008-06-11	2015-06-10	激光基因公司	核苷酸和核苷以及将其用于dna测序的方法
US20110281917A1 (en)	2009-01-29	2011-11-17	Darrin Stuart	Substituted Benzimidazoles for the Treatment of Astrocytomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru)	2009-08-12	2012-09-28	Новартис Аг	Гетероциклические гидразоны и их применение для лечения рака и воспаления
AU2010284254B2 (en)	2009-08-17	2015-09-17	Intellikine, Llc	Heterocyclic compounds and uses thereof
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en)	2011-02-23	2012-08-30	Intellikine, Llc	Heterocyclic compounds and uses thereof
AU2012220572A1 (en)	2011-02-25	2013-08-29	Irm Llc	Compounds and compositions as trk inhibitors
EA026655B1 (ru)	2011-09-15	2017-05-31	Новартис Аг	6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
JP6130391B2 (ja)	2011-11-23	2017-05-17	インテリカイン，エルエルシー	Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
US20150297604A1 (en)	2012-04-03	2015-10-22	Novartis Ag	Combination Products with Tyrosine Kinase Inhibitors and their Use
CN105246482A (zh)	2013-03-15	2016-01-13	因特利凯有限责任公司	激酶抑制剂的组合及其用途
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
JP6526789B2 (ja)	2014-07-31	2019-06-05	ノバルティスアーゲー	組み合わせ療法
CA3102279A1 (en)	2018-06-01	2019-12-05	Cornell University	Combination therapy for pi3k-associated disease or disorder
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8276187A (en) *	1986-10-31	1988-05-25	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
IL107101A0 (en) *	1992-09-30	1993-12-28	Merrell Dow Pharma	2-substituted adenosines with a-2 receptor affinity
GB9723590D0 (en) *	1997-11-08	1998-01-07	Glaxo Group Ltd	Chemical compounds
WO1999034804A1 (en) *	1998-01-08	1999-07-15	The University Of Virginia Patent Foundation	A2a adenosine receptor agonists
BR9914526A (pt) *	1998-10-16	2001-07-03	Pfizer	Derivados de adenina
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB9924361D0 (en) *	1999-10-14	1999-12-15	Pfizer Ltd	Purine derivatives
GB9924363D0 (en) *	1999-10-14	1999-12-15	Pfizer Central Res	Purine derivatives

2000
- 2000-06-27 GB GBGB0015727.1A patent/GB0015727D0/en not_active Ceased
2001
- 2001-06-14 CN CN01810621A patent/CN1432020A/zh active Pending
- 2001-06-14 IL IL15252901A patent/IL152529A0/xx unknown
- 2001-06-14 CZ CZ20023992A patent/CZ20023992A3/cs unknown
- 2001-06-14 AT AT01938490T patent/ATE267836T1/de not_active IP Right Cessation
- 2001-06-14 BR BR0111912-5A patent/BR0111912A/pt not_active IP Right Cessation
- 2001-06-14 AU AU2001264164A patent/AU2001264164A1/en not_active Abandoned
- 2001-06-14 HR HR20020995A patent/HRP20020995A2/hr not_active Application Discontinuation
- 2001-06-14 CA CA002412564A patent/CA2412564C/en not_active Expired - Fee Related
- 2001-06-14 ES ES01938490T patent/ES2220775T3/es not_active Expired - Lifetime
- 2001-06-14 EP EP01938490A patent/EP1296996B1/en not_active Expired - Lifetime
- 2001-06-14 HU HU0301389A patent/HUP0301389A3/hu unknown
- 2001-06-14 KR KR1020027017723A patent/KR20030036248A/ko not_active Ceased
- 2001-06-14 DK DK01938490T patent/DK1296996T3/da active
- 2001-06-14 DE DE60103537T patent/DE60103537T2/de not_active Expired - Fee Related
- 2001-06-14 SK SK1733-2002A patent/SK17332002A3/sk unknown
- 2001-06-14 PT PT01938490T patent/PT1296996E/pt unknown
- 2001-06-14 PL PL36138401A patent/PL361384A1/xx not_active Application Discontinuation
- 2001-06-14 EA EA200201291A patent/EA200201291A1/ru unknown
- 2001-06-14 SI SI200130136T patent/SI1296996T1/xx unknown
- 2001-06-14 WO PCT/IB2001/001064 patent/WO2002000676A1/en not_active Ceased
- 2001-06-14 MX MXPA03000078A patent/MXPA03000078A/es active IP Right Grant
- 2001-06-14 NZ NZ521867A patent/NZ521867A/en unknown
- 2001-06-14 OA OA1200200387A patent/OA12294A/en unknown
- 2001-06-14 EE EEP200200712A patent/EE200200712A/xx unknown
- 2001-06-14 JP JP2002505798A patent/JP2004501929A/ja active Pending
- 2001-06-14 TR TR2004/01622T patent/TR200401622T4/xx unknown
- 2001-06-21 GT GT200100119A patent/GT200100119A/es unknown
- 2001-06-21 AP APAP/P/2001/002193A patent/AP1372A/en active
- 2001-06-22 DO DO2001000195A patent/DOP2001000195A/es unknown
- 2001-06-25 PA PA20018521001A patent/PA8521001A1/es unknown
- 2001-06-25 PE PE2001000615A patent/PE20020213A1/es not_active Application Discontinuation
- 2001-06-26 SV SV2001000507A patent/SV2002000507A/es not_active Application Discontinuation
- 2001-06-26 AR ARP010103038A patent/AR028759A1/es unknown
- 2001-06-26 TN TNTNSN01096A patent/TNSN01096A1/fr unknown
- 2001-06-26 UY UY26797A patent/UY26797A1/es not_active Application Discontinuation
2002
- 2002-10-07 BG BG107171A patent/BG107171A/xx unknown
- 2002-10-10 IS IS6580A patent/IS6580A/is unknown
- 2002-11-25 ZA ZA200209557A patent/ZA200209557B/en unknown
- 2002-12-12 NO NO20025975A patent/NO20025975L/no not_active Application Discontinuation
- 2002-12-19 EC EC2002004396A patent/ECSP024396A/es unknown
- 2002-12-20 MA MA26970A patent/MA26918A1/fr unknown

Also Published As

Publication number	Publication date
UY26797A1 (es)	2002-01-31
KR20030036248A (ko)	2003-05-09
NO20025975D0 (no)	2002-12-12
DE60103537D1 (de)	2004-07-01
EE200200712A (et)	2004-06-15
MXPA03000078A (es)	2003-08-19
SI1296996T1 (en)	2004-10-31
WO2002000676A1 (en)	2002-01-03
ATE267836T1 (de)	2004-06-15
AR028759A1 (es)	2003-05-21
OA12294A (en)	2003-11-14
DK1296996T3 (da)	2004-08-16
CZ20023992A3 (cs)	2003-12-17
GT200100119A (es)	2002-01-31
DOP2001000195A (es)	2002-05-15
EA200201291A1 (ru)	2003-04-24
EP1296996A1 (en)	2003-04-02
AU2001264164A1 (en)	2002-01-08
CN1432020A (zh)	2003-07-23
SK17332002A3 (sk)	2004-03-02
HUP0301389A3 (en)	2005-02-28
HUP0301389A2 (hu)	2003-08-28
JP2004501929A (ja)	2004-01-22
CA2412564A1 (en)	2002-01-03
EP1296996B1 (en)	2004-05-26
DE60103537T2 (de)	2005-07-07
ES2220775T3 (es)	2004-12-16
TR200401622T4 (tr)	2004-08-23
PT1296996E (pt)	2004-08-31
ECSP024396A (es)	2003-02-06
PA8521001A1 (es)	2002-04-25
BR0111912A (pt)	2003-05-13
MA26918A1 (fr)	2004-12-20
TNSN01096A1 (fr)	2005-11-10
GB0015727D0 (en)	2000-08-16
AP1372A (en)	2005-02-21
NZ521867A (en)	2004-04-30
IL152529A0 (en)	2003-05-29
BG107171A (en)	2003-07-31
PL361384A1 (en)	2004-10-04
PE20020213A1 (es)	2002-03-19
NO20025975L (no)	2002-12-12
CA2412564C (en)	2007-10-02
SV2002000507A (es)	2002-07-03
HRP20020995A2 (en)	2005-02-28
ZA200209557B (en)	2003-12-02

Publication	Publication Date	Title
ATE325807T1 (de)	2006-06-15	Purinderivate
DE60103537D1 (de)	2004-07-01	Purinderivate
ATE431356T1 (de)	2009-05-15	2-aminocarbonyl-9h-purinderivative
DE60116260D1 (de)	2006-02-02	Antivirale azaindolderivate
ATE321065T1 (de)	2006-04-15	Purin-derivate
DE60002356D1 (de)	2003-05-28	Purin-derivate
IS6196A (is)	2001-12-11	Púrín afleiður
ATE372988T1 (de)	2007-09-15	Pyrimidin-derivate
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
ATE280752T1 (de)	2004-11-15	Aminomethyl-phenyl-cyclohexanonderivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
EP1295891A4 (en)	2004-05-26	Nucleoside derivatives